Can a Follow-Up drug keep bones strong after initial osteoporosis therapy?
Disease control
Recruiting now
This study looks at postmenopausal women with severe osteoporosis who have finished a course of either romosozumab or teriparatide. Researchers want to see which follow-up drug—zoledronate, denosumab, teriparatide, romosozumab, or abaloparatide—best maintains or improves bone den…
Sponsor: 424 General Military Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC